(3R)-3,7-Dimethyloct-6-en-1-ol
Strength: |
medium |
Evidences: |
14769939
Godfrey PA, Malnic B, Buck LB. The mouse olfactory receptor gene family. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2156-61. doi: 10.1073/pnas.0308051100. Epub 2004 Feb 9.
|
15598656
Shirokova E, Schmiedeberg K, Bedner P, Niessen H, Willecke K, Raguse JD, Meyerhof W, Krautwurst D. Identification of specific ligands for orphan olfactory receptors. G protein-dependent agonism and antagonism of odorants. J Biol Chem. 2005 Mar 25;280(12):11807-15. doi: 10.1074/jbc.M411508200.
|
17601748
Schmiedeberg K, Shirokova E, Weber HP, Schilling B, Meyerhof W, Krautwurst D. Structural determinants of odorant recognition by the human olfactory receptors OR1A1 and OR1A2. J Struct Biol. 2007 Sep;159(3):400-12. doi: 10.1016/j.jsb.2007.04.013.
|
19261596
Saito H, Chi Q, Zhuang H, Matsunami H, Mainland JD. Odor coding by a Mammalian receptor repertoire. Sci Signal. 2009 Mar 3;2(60):ra9. doi: 10.1126/scisignal.2000016.
|
|
Common Name: |
(3R)-3,7-Dimethyloct-6-en-1-ol |
IUPAC Name: |
(3R)-3,7-dimethyloct-6-en-1-ol |
Molecular Formula: |
C10H20O |
SMILES: |
CC(CCC=C(C)C)CCO |
Inchi: |
1S/C10H20O/c1-9(2)5-4-6-10(3)7-8-11/h5,10-11H,4,6-8H2,1-3H3/t10-/m1/s1 |
Inchi Key: |
QMVPMAAFGQKVCJ-SNVBAGLBSA-N |
Cas No: |
1117-61-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
156.27 |
Mass (g/mol) |
156.151 |
Molar Refractivity |
50.87 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
5 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
221.00 to 224.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.018 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
2.751 |
iLOGP |
2.72 |
XLOGP3 |
3.91 |
WLOGP |
2.75 |
MLOGP |
2.70 |
ESOL Log S |
-2.94 |
ESOL Solubility (mg/ml) |
0.179 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.03 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.21 |
Silicos-IT Solubility (mg/ml) |
0.96 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.48 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.769 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.077 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |